Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3)

Clinical trial NCT05860114 · COMPLETED

Trial details

NCT number: NCT05860114
Sponsor: Italfarmaco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Drug Interaction

Start date: 2022-03-21
Primary completion: 2022-05-08
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.